Skip to content

Clinical trials

Pathologic Complete Response trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20121
20131
20171
20181
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Heidelberg University1
Krankenhaus Nordwest1
LMU Klinikum1
Sellas Life Sciences Group1
Synimmune GmbH1
Takeda1
University Hospital Tuebingen1
University Medical Center Groningen1
Xenikos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response11
Leukemia, Myeloid, Acute3
Aspergillosis1
Carcinoma, Ovarian Epithelial1
Carcinoma, Transitional Cell1
Fallopian Tube Neoplasms1
Gastroesophageal Reflux1
Hypersensitivity1
Hyperthermia1
Leukemia1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.